JPH0560810B2 - - Google Patents
Info
- Publication number
- JPH0560810B2 JPH0560810B2 JP61135561A JP13556186A JPH0560810B2 JP H0560810 B2 JPH0560810 B2 JP H0560810B2 JP 61135561 A JP61135561 A JP 61135561A JP 13556186 A JP13556186 A JP 13556186A JP H0560810 B2 JPH0560810 B2 JP H0560810B2
- Authority
- JP
- Japan
- Prior art keywords
- ibuprofen
- magnesium stearate
- formulation
- lactose
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 34
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims description 27
- 229960001680 ibuprofen Drugs 0.000 claims description 27
- 235000019359 magnesium stearate Nutrition 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 description 24
- 238000009472 formulation Methods 0.000 description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 11
- 239000008101 lactose Substances 0.000 description 11
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 10
- 235000012239 silicon dioxide Nutrition 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000000454 talc Substances 0.000 description 7
- 229910052623 talc Inorganic materials 0.000 description 7
- 239000007963 capsule composition Substances 0.000 description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 239000001116 FEMA 4028 Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 2
- 229960004853 betadex Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical class CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Chemical class CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- -1 troches Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61135561A JPS62292718A (ja) | 1986-06-11 | 1986-06-11 | 経口製剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61135561A JPS62292718A (ja) | 1986-06-11 | 1986-06-11 | 経口製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62292718A JPS62292718A (ja) | 1987-12-19 |
JPH0560810B2 true JPH0560810B2 (pt) | 1993-09-03 |
Family
ID=15154688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61135561A Granted JPS62292718A (ja) | 1986-06-11 | 1986-06-11 | 経口製剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62292718A (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5409709A (en) * | 1991-11-29 | 1995-04-25 | Lion Corporation | Antipyretic analgesic preparation containing ibuprofen |
JP2005035995A (ja) * | 2003-07-01 | 2005-02-10 | Sankyo Co Ltd | イブプロフェン含有経口用組成物 |
JP2011052023A (ja) * | 2003-07-01 | 2011-03-17 | Daiichi Sankyo Healthcare Co Ltd | イブプロフェン含有経口用組成物 |
AT511581A1 (de) * | 2011-05-26 | 2012-12-15 | G L Pharma Gmbh | Orale retardierende formulierung |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56154416A (en) * | 1980-04-30 | 1981-11-30 | Kaken Pharmaceut Co Ltd | Antipyretic analgesic composition |
-
1986
- 1986-06-11 JP JP61135561A patent/JPS62292718A/ja active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56154416A (en) * | 1980-04-30 | 1981-11-30 | Kaken Pharmaceut Co Ltd | Antipyretic analgesic composition |
Also Published As
Publication number | Publication date |
---|---|
JPS62292718A (ja) | 1987-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940002659B1 (ko) | 치료제 조성물의 제조방법 | |
US4831058A (en) | Therapeutic agents | |
US20110177168A1 (en) | Composition | |
AU676315B2 (en) | Stabilized solid pharmaceutical preparation and method of producing the same | |
AP1084A (en) | Swalow tablet comprising paracetamol. | |
JPH0122245B2 (pt) | ||
JPH0272115A (ja) | イブプロフェン又はその塩を活物質とする可溶性の消炎性組成物及びその製造方法 | |
JPS6379833A (ja) | 月経困難症及び/又は月経前症候群の軽減用薬剤組成物とその調製法 | |
KR890000182B1 (ko) | 액상 윤활제-함유 약제학적 조성물 및 약제학적 제형의 용해도 개선방법 | |
PT85871B (en) | Process for the preparation of orally administrable pharmaceutical compositions which contain chenodeoxycholic acid or deoxycholic acid or a salt of either of these acids any of wich may be used alone or is combination with a synergist | |
JPS63406B2 (pt) | ||
JPH0560810B2 (pt) | ||
KR100267525B1 (ko) | 시타라빈 옥포스페이트 경질 캡슐제 | |
EP0599767B1 (en) | Process to prepare water-dispersable tablets containing diclofenac | |
JPS6357521A (ja) | 経口製剤 | |
JP2750130B2 (ja) | 経口投与用組成物 | |
WO2003070217A1 (en) | Levothyroxine compositions and methods | |
JP2005029557A (ja) | 口腔内速崩壊性錠剤およびその製造方法 | |
JP2928261B2 (ja) | 安定なポリプレニル系化合物含有組成物の製法 | |
RU2174836C1 (ru) | Фармацевтическая композиция, обладающая анальгезирующим действием | |
JPS6360926A (ja) | 感冒薬 | |
JPH06100447A (ja) | イミダプリル含有製剤 | |
JP2022120384A (ja) | ヨウ化イソプロパミド含有医薬 | |
JPH0528689B2 (pt) | ||
WO1996025158A1 (fr) | Composition a base de derives de l'azulene et son procede d'obtention |